Literature DB >> 18686005

Pharmacological treatments and risks for the food chain.

C Girardi1, R Odore.   

Abstract

Veterinarians play a pivotal role in public health control, in particular in the management of risks deriving from pharmacological treatments of food-producing animals. Veterinary medicinal products can represent a risk for animal health and welfare (side effects, decreased efficacy), for farmers and practitioners administering the drug, for consumers of food of animal origin (presence of residues, occurrence of antibiotic resistance) and for the environment. According to pending European guidelines, risk management starts from marketing authorisation that must be based on risk evaluation and can be denied when the risk/benefit ratio is not favourable considering the advantages for animal health and welfare and for safety of consumers. Veterinarians can prevent and control risks by using correct pharmacological criteria to choose and administer medicinal products and undertaking risk-based inspection of residues of drugs in food of animal origin. Moreover, a major tool for veterinarians to prevent and control drug-borne risk is "pharmacovigilance". Risks for the environment are usually assessed during the pre-marketing approval process, however veterinarians, as risk managers, should educate farmers about correct drug handling and disposal, and periodically verify that suggested measures are applied.

Mesh:

Year:  2008        PMID: 18686005     DOI: 10.1007/s11259-008-9083-5

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  19 in total

1.  Occurrence of antibiotics in the aquatic environment.

Authors:  R Hirsch; T Ternes; K Haberer; K L Kratz
Journal:  Sci Total Environ       Date:  1999-01-12       Impact factor: 7.963

Review 2.  Veterinary pharmacovigilance: between regulation and science.

Authors:  G Keck; C Ibrahim
Journal:  J Vet Pharmacol Ther       Date:  2001-12       Impact factor: 1.786

3.  Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry.

Authors:  Sara Castiglioni; Ettore Zuccato; Elisabetta Crisci; Chiara Chiabrando; Roberto Fanelli; Renzo Bagnati
Journal:  Anal Chem       Date:  2006-12-15       Impact factor: 6.986

4.  Health management with reduced antibiotic use - experiences of a Danish pig vet.

Authors:  Hans Møller Jensen
Journal:  Anim Biotechnol       Date:  2006       Impact factor: 2.282

5.  Food poisoning by clenbuterol in Portugal.

Authors:  Jorge Barbosa; Clara Cruz; José Martins; José Manuel Silva; Celeste Neves; Carlos Alves; Fernando Ramos; Maria Irene Noronha Da Silveira
Journal:  Food Addit Contam       Date:  2005-06

6.  Analysis of reports of human exposure to Micotil 300 (tilmicosin injection).

Authors:  Melissa F Veenhuizen; Theressa J Wright; Robert F McManus; Jane G Owens
Journal:  J Am Vet Med Assoc       Date:  2006-12-01       Impact factor: 1.936

7.  Presence of macrolide-lincosamide-streptogramin B and tetracycline antimicrobials in swine waste treatment processes and amended soil.

Authors:  Julie Zilles; Toshio Shimada; Archana Jindal; Matt Robert; Lutgarde Raskin
Journal:  Water Environ Res       Date:  2005 Jan-Feb       Impact factor: 1.946

Review 8.  Epidemiology of resistance to antibiotics. Links between animals and humans.

Authors:  A E van den Bogaard; E E Stobberingh
Journal:  Int J Antimicrob Agents       Date:  2000-05       Impact factor: 5.283

9.  Prioritising veterinary medicines according to their potential indirect human exposure and toxicity profile.

Authors:  Alexander C Capleton; Carol Courage; Paul Rumsby; Philip Holmes; Edward Stutt; Alistair B A Boxall; Leonard S Levy
Journal:  Toxicol Lett       Date:  2006-02-28       Impact factor: 4.372

10.  Guidelines for prudent use of antimicrobials and their implications on antibiotic usage in veterinary medicine.

Authors:  Fritz R Ungemach; Dagmar Müller-Bahrdt; Getu Abraham
Journal:  Int J Med Microbiol       Date:  2006-06       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.